Berenberg Upgrades AstraZeneca To Buy
Berenberg upgraded AstraZeneca plc (ADR) (NYSE: AZN) from Hold to Buy.
AstraZeneca shares have dropped 14.54 percent over the past 52 weeks, while the S&P 500 index has surged 4.63 percent in the same period.
AstraZeneca shares jumped 1.44 percent to close at $64.63 yesterday.
Latest Ratings for AZN
Date | Firm | Action | From | To |
---|---|---|---|---|
Feb 2022 | SVB Leerink | Maintains | Outperform | |
Feb 2022 | DZ Bank | Upgrades | Sell | Hold |
Dec 2021 | Jefferies | Downgrades | Buy | Hold |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: BerenbergUpgrades Analyst Ratings